What question did this study set out to answer?

The aim is to evaluate the effectiveness of mechanical circulatory support in patients with cardiogenic shock following acute myocardial infarction.

Mechanical Support in Myocardial Infarction Complicated by Cardiogenic Shock: What Have We Learned from Trials?

View Full Paper

Ask AI

Bookmark

The aim is to evaluate the effectiveness of mechanical circulatory support in patients with cardiogenic shock following acute myocardial infarction.
Literature review of recent trials involving temporary mechanical circulatory support devices.
Highlighted trials include the IABP-SHOCK II, DanGer Shock, ECLS-SHOCK, and ECMO-CS.
Discussion of real-world data contrast and adherence to trial inclusion criteria.
IABP-SHOCK II reported no reduction in 30-day mortality with IABP, supporting a Class III recommendation.
DanGer Shock showed a 12.7% absolute mortality reduction at 180 days with MAFP in selected patients.
ECLS-SHOCK and ECMO-CS trials indicated no survival improvement with VA-ECMO and noted high complication rates.

No takes yet. Share an insight, caveat, or question.

Reviewing trials reveals individualized mechanical support may optimize outcomes in AMI complicated by shock.

Aurigemma et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark